Literature DB >> 26876037

Identifying clinical measures that most accurately reflect the progression of disability in Parkinson disease.

Terry D Ellis1, James T Cavanaugh2, Gammon M Earhart3, Matthew P Ford4, K Bo Foreman5, Anne Thackeray5, Matthew S Thiese6, Leland E Dibble5.   

Abstract

INTRODUCTION: The temporal relationship between disease and disability progression in Parkinson disease (PD) is not well understood. Our objective was to describe the natural, multidimensional trajectory of disability in persons with PD over a two-year period.
METHODS: We conducted a multi-center, prospective cohort study involving four institutions. Data were collected at baseline and at 6-month intervals over 2 years using standardized clinical tests representing three World Health Organization defined disability domains: impairment, activity limitation, and participation restriction. Unadjusted mixed effects growth models characterized trajectories of disability in the three disability domains. The data set was analyzed using restricted maximum likelihood (REML) estimation. Standardized estimates of change were also computed using Cohen's d for each measure.
RESULTS: Of the 266 enrolled participants, we analysed data from individuals who participated in at least 3 assessments (n = 207, 79%). Rates of disability progression over the 2-year period differed across domains. Moderate effects were detected for motor impairment (d = .28) and walking-related activity limitation (gait-related balance (d = .31); gait speed (d = .30)). Marginal effects were noted for upper extremity-related activity limitation (d = .11) and health-related quality of life participation restriction (d = .08).
CONCLUSIONS: The natural trajectory of walking-related activity limitation was the most potent indicator of evolving disability, suggesting that routine assessment of walking and periodic rehabilitation is likely to be warranted for many persons with PD. Natural trajectories of disability provide important comparison data for future intervention studies.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disability; Natural history; Parkinson disease; Progression

Mesh:

Year:  2016        PMID: 26876037     DOI: 10.1016/j.parkreldis.2016.02.006

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  20 in total

1.  Dynamics of change in self-reported disability among persons with Parkinson's disease after 2 years of follow-up.

Authors:  Tatjana Gazibara; Darija Kisic-Tepavcevic; Marina Svetel; Aleksandra Tomic; Iva Stankovic; Vladimir Kostic; Tatjana Pekmezovic
Journal:  Neurol Sci       Date:  2017-05-13       Impact factor: 3.307

2.  Spatiotemporal quantification of gait in common marmosets.

Authors:  Kristen A Pickett; Nancy Schultz-Darken; Abigail F Bradfield; Kerri Malicki; Bruce Pape; Karla K Ausderau; Marina E Emborg
Journal:  J Neurosci Methods       Date:  2019-11-12       Impact factor: 2.390

3.  Usability of a daily mHealth application designed to address mobility, speech and dexterity in Parkinson's disease.

Authors:  Adam P Horin; Marie E McNeely; Elinor C Harrison; Peter S Myers; Ellen N Sutter; Kerri S Rawson; Gammon M Earhart
Journal:  Neurodegener Dis Manag       Date:  2019-04-18

Review 4.  Deep brain stimulation improves gait velocity in Parkinson's disease: a systematic review and meta-analysis.

Authors:  Jaimie A Roper; Nyeonju Kang; Juliana Ben; James H Cauraugh; Michael S Okun; Chris J Hass
Journal:  J Neurol       Date:  2016-04-28       Impact factor: 4.849

Review 5.  Evidence for Early and Regular Physical Therapy and Exercise in Parkinson's Disease.

Authors:  Terry D Ellis; Cristina Colón-Semenza; Tamara R DeAngelis; Cathi A Thomas; Marie-Hélène Saint Hilaire; Gammon M Earhart; Leland E Dibble
Journal:  Semin Neurol       Date:  2021-03-19       Impact factor: 3.420

6.  The sobering and puzzling reality of rehabilitation referrals for Parkinson disease.

Authors:  Leland E Dibble; Theresa D Ellis
Journal:  Parkinsonism Relat Disord       Date:  2021-02-01       Impact factor: 4.891

7.  Levodopa facilitates improvements in gait kinetics at the hip, not the ankle, in individuals with Parkinson's disease.

Authors:  Sidney T Baudendistel; Abigail C Schmitt; Ryan T Roemmich; Isobel L Harrison; Chris J Hass
Journal:  J Biomech       Date:  2021-03-24       Impact factor: 2.789

Review 8.  Algorithms for the treatment of motor problems in Parkinson's disease.

Authors:  E Dietrichs; P Odin
Journal:  Acta Neurol Scand       Date:  2017-01-30       Impact factor: 3.209

9.  Are Mobile Persons With Parkinson Disease Necessarily More Active?

Authors:  Jenna A Zajac; James T Cavanaugh; Teresa Baker; Cristina Colón-Semenza; Tamara R DeAngelis; Ryan P Duncan; Daniel Fulford; Michael LaValley; Timothy Nordahl; Kerri S Rawson; Marie Saint-Hilaire; Cathi A Thomas; Gammon M Earhart; Terry D Ellis
Journal:  J Neurol Phys Ther       Date:  2021-10-01       Impact factor: 4.655

10.  EMPOWER-PD - A physical therapy intervention to empower the individuals with Parkinson's disease: a study protocol for a feasibility randomized controlled trial.

Authors:  Helena de Oliveira Braga; Elaine Cristina Gregório; Rafaela Simon Myra; Ana Sofia Kauling de Souza; Talita Vitorina Kunh; Jessica Klug; Adriana Coutinho de Azevedo Guimarães; Alessandra Swarowsky
Journal:  Pilot Feasibility Stud       Date:  2019-01-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.